Orbimed Advisors LLC Portfolio Holdings

Orbimed Advisors LLC

  • $4.24 Billion
  • Q3 2024

Orbimed Advisors LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $4.24 Billion distributed in 119 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Edgewise Therapeutics, Inc. with a value of $401M, Eli Lilly & CO with a value of $299M, Boston Scientific Corp with a value of $274M, Intuitive Surgical Inc with a value of $213M, and Biogen Inc. with a value of $158M.

Examining the 13F form we can see an increase of $93.7M in the current position value, from $4.15B to 4.24B.

Orbimed Advisors LLC is based out at San Diego, CA

Below you can find more details about Orbimed Advisors LLC portfolio as well as his latest detailed transactions.

Portfolio value $4.24 Billion
Healthcare: $4.24 Billion

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$503M
$78.3 Million 1.85% of portfolio
5,779,071
Q3 2022 New
$1.44B
$59.2 Million 1.39% of portfolio
1,018,734
Q3 2024 Reduced 19.7%
$1.94B
$57.2 Million 1.35% of portfolio
1,258,566
Q3 2024 Reduced 57.76%
$1.09B
$47.1 Million 1.11% of portfolio
1,665,115
Q3 2024 Reduced 36.1%
$422M
$46.2 Million 1.09% of portfolio
3,305,801
Q3 2024 Added 2.35%
$910M
$37.1 Million 0.87% of portfolio
1,925,300
Q2 2024 Added 10.08%
$379M
$36.7 Million 0.86% of portfolio
6,943,654
Q3 2021 Reduced 13.78%
$1.27B
$29.9 Million 0.7% of portfolio
675,872
Q1 2024 Reduced 55.48%
$944M
$26.8 Million 0.63% of portfolio
3,573,000
Q3 2024 Added 54.0%
$370M
$26.2 Million 0.62% of portfolio
1,449,073
Q3 2024 New
$1.54B
$25.4 Million 0.6% of portfolio
708,400
Q1 2024 New
$578M
$22.9 Million 0.54% of portfolio
2,006,381
Q2 2024 Added 13.37%
$645M
$18.1 Million 0.43% of portfolio
768,638
Q1 2024 New
$557M
$17.9 Million 0.42% of portfolio
1,070,055
Q3 2024 Reduced 6.76%
$787M
$10.8 Million 0.26% of portfolio
4,180,768
Q3 2021 Reduced 32.82%
$1.38B
$5.95 Million 0.14% of portfolio
742,300
Q3 2024 Reduced 30.91%
$505M
$5.72 Million 0.13% of portfolio
1,728,300
Q3 2024 Reduced 28.75%
$521M
$1.48 Million 0.03% of portfolio
1,927,000
Q4 2023 Reduced 64.73%
$413M
$229,000 0.01% of portfolio
80,420
Q1 2024 New

Summary

  • Portfolio
  • No. of Stocks 119
  • Current Value $4.24 Billion
  • Prior Value $4.15 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 19 stocks
  • Additional Purchases 19 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 29 stocks
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email